XML 53 R41.htm IDEA: XBRL DOCUMENT v3.24.3
LEASES (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 01, 2021
USD ($)
Sep. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
item
Jan. 31, 2021
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Apr. 30, 2021
USD ($)
Apr. 01, 2020
USD ($)
LEASES:                      
Operating lease lability         $ 13,000,742   $ 13,000,742   $ 13,270,295    
Right of use asset         $ 11,651,563   $ 11,651,563   $ 12,058,896    
Incremental borrowing rate         9.80%   9.80%        
Operating lease paid         $ 547,000 $ 633,000 $ 1,684,000 $ 1,801,000      
Weighted average remaining lease term         11 years 10 months 24 days   11 years 10 months 24 days   12 years 8 months 12 days    
CytoSorbents Medical, Inc                      
LEASES:                      
Number of times lease renewal options available | item     2                
Renewal term     5 years                
Rent abatement term     6 months                
CytoSorbents Europe GmbH                      
LEASES:                      
Monthly payments of base rent and other costs       $ 7,784              
Operating lease lability                     $ 594,000
Right of use asset                     $ 594,000
Area of Land | m²       1,068              
Other costs $ 239                    
Lease term 5 years                    
Existence of option to extend true                    
Additional lessee operating lease term of contract option to extend 5 years                    
United States | CytoSorbents Medical, Inc                      
LEASES:                      
Remaining lease term     15 years 6 months                
Annual rent expense increment rate     2.75%                
Percentage of total building space occupied     92.30%                
Allowance for building improvement     $ 1,455,000                
Operating lease lability $ 11,600,000                    
Right of use asset $ 11,600,000                    
Incremental borrowing rate 9.80%                    
United States | Letter of credit | CytoSorbents Medical, Inc                      
LEASES:                      
Security amount                   $ 1,467,000  
United States | Initial early term | CytoSorbents Medical, Inc                      
LEASES:                      
Monthly payments of base rent and other costs     25,208                
United States | Early term | CytoSorbents Medical, Inc                      
LEASES:                      
Monthly payments of base rent and other costs     88,254                
United States | Early term | CytoSorbents Medical, Inc                      
LEASES:                      
Monthly payments of base rent and other costs     $ 111,171                
Germany                      
LEASES:                      
Monthly payments of base rent and other costs   $ 12,100                  
Additional operating leases rent expense   $ 3,000